what drugs are glp 1 The Landscape Of GLP-1 Receptor Agonists In Diabetes And Obesity Treatment Market Overview: GLP-1 Agonists and

Ascletis ASC35, a once-monthly GLP-1/GIP peptide using a self-assembling lipid depot, cleared FDA IND for Phase 1 head-to-head vs weekly tirzepatide June 23.

How GLP-1 and GIP pathways work, why dual-action tirzepatide (Mounjaro) differs from GLP-1-only medicines, and what trial averages mean for UK patients.

Another systematic review of randomized trials found that muscle-related indices often exceeded the usual benchmark of about 25% of weight loss coming from fat-free mass

Evaluating what the research shows about GLP-1 medications and depression and suicidal ideation.

Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain